Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000002

Chairperson & CEO sold 9,500 shares at an average $515.37 ($4,896,019)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

19 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $146.03 $1,387,285 9,630 D
2026-03-02 Sale : show line 2 in the form 10b5-1 −160 $507.27 $81,163 9,470 D
2026-03-02 Sale : show line 3 in the form 10b5-1 −319 $508.49 $162,208 9,151 D
2026-03-02 Sale : show line 4 in the form 10b5-1 −427 $509.66 $217,625 8,724 D
2026-03-02 Sale : show line 5 in the form 10b5-1 −311 $511.05 $158,936 8,413 D
2026-03-02 Sale : show line 6 in the form 10b5-1 −722 $511.95 $369,627 7,691 D
2026-03-02 Sale : show line 7 in the form 10b5-1 −1,360 $512.83 $697,452 6,331 D
2026-03-02 Sale : show line 8 in the form 10b5-1 −1,042 $514.02 $535,610 5,289 D
Open-market sales · 9,500 sh · avg $515.37 · $4,896,019

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-02 Exercise or conversion : show line 20 in the form 10b5-1 Stock Option −9,500 230,500 D
Loading xslF345X05/primarydocument.xml…